Related Experiment Video
Updated: Apr 27, 2026
09:48
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
7.8K
Update on prognostic markers for endometrial cancer
Pratibha S Binder1, David G Mutch
1Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Washington University School of Medicine in St Louis, MO, USA.
Women'S Health (London, England)
|June 24, 2014
Summary
Endometrial cancer, a common gynecologic malignancy, often presents with early symptoms. Research is identifying molecular changes to improve classification and personalize treatments for better patient outcomes.
Area of Science:
- Gynecologic Oncology
- Cancer Genomics
- Molecular Pathology
Background:
- Endometrial cancer is the most common gynecologic cancer in the USA and second globally.
- Early diagnosis is common due to symptoms, leading to favorable survival in most cases.
- A subset of endometrial cancers exhibits a poorer prognosis, necessitating advanced treatment strategies.
Purpose of the Study:
- To explore molecular alterations in endometrial cancer for improved classification.
- To identify novel mutations and molecular profiles for personalized adjuvant therapy.
- To enhance treatment strategies through genome-guided targeted therapy.
Main Methods:
- Review of current clinical and pathologic prognostic factors.
- Analysis of recent research on molecular changes and histologic subtypes.
- Focus on identifying novel mutations and molecular profiles.
Main Results:
- Clinical and pathologic factors are established for adjuvant therapy decisions.
- Research is actively identifying molecular drivers for improved endometrial cancer classification.
- Novel mutations and molecular profiles are emerging as targets for personalized medicine.
Conclusions:
- Personalized adjuvant treatment using genome-guided targeted therapy is a promising future direction.
- Understanding molecular profiles is key to improving endometrial cancer classification and treatment.
- Further research into molecular changes will enhance prognostic accuracy and therapeutic options.
